Exagen
XGN
29 hedge funds and large institutions have $16.7M invested in Exagen in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
4% more funds holding
Funds holding: 28 → 29 (+1)
0.18% less ownership
Funds ownership: 40.9% → 40.72% (-0.18%)
16% less capital invested
Capital invested by funds: $20M → $16.7M (-$3.29M)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$391K |
| 2 |
Prudential Financial
Newark,
New Jersey
|
+$26.9K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.7K |
| 4 |
Millennium Management
New York
|
+$3.08K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$367K |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$38.4K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$34.1K |
| 4 |
BlackRock
New York
|
-$17.7K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$16.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $5.58K | +$35 | +14 | +0.6% |
|
|
SOW
27
State of Wyoming
Cheyenne,
Wyoming
| $1.59K | +$1.65K | +649 | New |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $1.57K | – | – | – |
|
29
Qube Research & Technologies (QRT)
London,
United Kingdom
| $500 | +$517 | +204 | New |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| – | -$188 | -65 | Closed |
|
XGN Hedge Fund Activity: Q3 2023 in Review
29 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q3 2023, worth a combined $16.7M — down 16% from $20M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new XGN positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Stonepine Capital Management, adding an estimated $391K. The largest seller was Wasatch Advisors, cutting an estimated $367K.
- 29 institutional investors held Exagen (XGN) as of Q3 2023, up from 28 in Q2 2023.
- Funds reported $16.7M of Exagen stock for Q3 2023, down 16% quarter-over-quarter.
- 3 funds opened new Exagen positions in Q3 2023 and 1 closed out, a net change of +2 holders.
- The largest Exagen buyer in Q3 2023 was Stonepine Capital Management, an estimated $391K added.
- The largest Exagen seller in Q3 2023 was Wasatch Advisors, an estimated $367K sold.
Based on aggregated 13F filings for Q3 2023.